Components of Placebo Effects in Sadness

NACompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

January 31, 2020

Conditions
Dysphoric Mood
Interventions
OTHER

OLP scientifically-objective

Participants are informed that they are about to take a placebo. The rationale for the effectivity of placebos is explained in a scientifically-objective manner.

OTHER

OLP personally-affective

Participants are informed that they are about to take a placebo. The rationale for the effectivity of placebos is explained in a personally-affective manner.

OTHER

DP scientifically-objective

Participants are informed that they are about to take an effective antidepressant. The rationale for the effectivity of the antidepressant is explained in a scientifically-objective manner.

OTHER

DP personally-affective

Participants are informed that they are about to take an effective antidepressant. The rationale for the effectivity of the antidepressant is explained in a personally-affective manner.

Trial Locations (1)

35032

Philipps-University of Marburg, Marburg

All Listed Sponsors
lead

Philipps University Marburg

OTHER

NCT03507959 - Components of Placebo Effects in Sadness | Biotech Hunter | Biotech Hunter